5-Year Rate Changes > Interpret
Interpretation of 5-Year Rate Changes Data
5-Year Rate Changes - IncidenceBar graph with 21 items
All Ages, Both Sexes, AI/AN (incl Hisp)
Since the overall trend is negative (-1.30 with a 95% confidence interval from -1.80 to -0.90 ), the overall cancer rate is falling.
The following cancers could not be calculated due to insufficient counts:
- Brain & ONS
- Breast (in situ) (Female)
- Cervix (Female)
- Melanoma of the Skin
- Ovary (Female)
Stable when 95% confidence interval of annual percent change includes 0.
The rate for the following cancers was statistically stable in the time period:
- Kidney & Renal Pelvis with a trend of -1.4 and a 95% confidence interval from -4.2 to 1.6.
- Breast (Female) with a trend of -0.9 and a 95% confidence interval from -2.3 to 0.4.
- Non-Hodgkin Lymphoma with a trend of -0.8 and a 95% confidence interval from -4.0 to 2.4.
- Pancreas with a trend of -0.4 and a 95% confidence interval from -3.1 to 2.3.
- Bladder with a trend of 0.2 and a 95% confidence interval from -3.0 to 3.4.
- Oral Cavity & Pharynx with a trend of 0.4 and a 95% confidence interval from -2.4 to 3.3.
- Liver & Bile Duct with a trend of 1.8 and a 95% confidence interval from -1.2 to 4.9.
- Uterus (Corp/Uterus NOS) (Fem) with a trend of 18.4 and a 95% confidence interval from -9.0 to 54.2.
Falling when 95% confidence interval of annual percent change is below 0.
The rate for the following cancers fell in the time period:
- Prostate (Male) with a trend of -6.2# and a 95% confidence interval from -7.9 to -4.5.
- Colon & Rectum with a trend of -2.7# and a 95% confidence interval from -3.8 to -1.6.
- Lung & Bronchus with a trend of -2.0# and a 95% confidence interval from -3.5 to -0.4.
Created by statecancerprofiles.cancer.gov on 09/19/2021 6:26 pm.
Source: Incidence data provided by the National Program of Cancer Registries (NPCR). SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).
AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2018 US Population Data File is used with SEER November 2020 data. Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html. Please note that the data comes from different sources. Due to different years of data availablility, most of the trends are AAPCs based on APCs but some are EAPCs calculated in SEER*Stat. Please refer to the source for each graph for additional information.
Statistics for minorities may be affected by inconsistent race identification between the cancer case reports (sources for numerator of rate) and data from the Census Bureau (source for denominator of rate); and from undercounts of some population groups in the census.